Home Kiadis Pharma

Kiadis Pharma

acquired
Post-IPO Round
Cancer Treatment Drug Developer
Basic
Enterprise Profile

Basic Information

Kiadis Pharma is a biopharmaceutical company focused on the complications and limitations of hematopoietic stem cell transplantation for patients with blood cancer. The company has three blood cancer products in clinical development, offering new treatment options for advanced cancer patients to address highly unmet medical needs.
Kiadis Pharma NV
--
15~50 people
January 01, 1997
--

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy
Technology
Immunological Techniques Cell Technology
Concept
Disease Treatment Tumor Leukemia
Application Scenarios
Innovative Drugs Cell and Gene Therapy